A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
N/A
The primary purpose of study is to estimate the incidence and comparative e...
Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
PHASE3
This study will evaluate whether the addition of sitagliptin reduces hemogl...
A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
PHASE3
Efficacy of BI 1356 compared to placebo in patients for whom metformin ther...
Status
Completed
Location
1218.50.10009 Boehringer Ingelheim Investigational Site